CAPhO Educational Webinar Series - They’re here – now what? Practical Considerations for Implementing Biosimilars now available online

The webinar They’re here – now what? Practical Considerations for Implementing Biosimilars presented by Kara Browne & Michelle Deschamps from Saskatchewan Cancer Agency, is now available online.

As a member, you can watch it at your leisure on the CAPhO website. Simply log in as a member and visit the Watch a Webinar page.

Understanding how biosimilars and reference drugs are “the same but different” will help pharmacy staff prepare for safely integrating these highly complex medications into our practice.

In one hour, Kara Browne & Michelle Deschamps will:

• Provide information about the basic concepts of biosimilar production and approval in Canada
• Review Health Canada’s regulations regarding biosimilars
• Discuss workflow considerations for biosimilar implementation from the point of product procurement tot eh final product check

Kara Browne received a Pharmacy Technician Certificate from Red Deer College in 1996 and became a registered Pharmacy Technician in 2017.  She started her career at Royal University Hospital in Saskatoon, SK and then spent 11 years working in Calgary, AB at both the Peter Lougheed Centre and the Alberta Children’s Hospital, where she worked in the dedicated oncology satellite pharmacy.  Kara joined the oncology pharmacy at the Saskatoon Cancer Centre in 2009 and is currently a Senior Pharmacy Technician.  Kara’s primary responsibilities include Clinical Trials and Patient Access Programs.

Michelle Deschamps obtained her pharmacy degree at the University of Saskatchewan in 1989 and returned to complete a Master’s degree in 2002.  Michelle has worked in a variety of practice settings including community pharmacy, hospital pharmacy, the Canadian Armed Forces, and the University of Saskatchewan College of Pharmacy and Nutrition conducting practice-based research. Michelle joined the Saskatchewan Cancer Agency in 2009 and is currently a Senior Oncology Pharmacist. She is a member of the education working group for the pan Canadian Biosimilar Oncology initiative.